Table 3.
Dosimetry
| Dosimetric parameters | Median value (min-max) |
|---|---|
| GTV Dave (BED10), Gy | 99 (54–139) |
| GTV Dmed (BED10), Gy | 99 (53–140) |
| GTV Dmin (BED10), Gy | 65 (39–120) |
| GTV Dmax (BED10), Gy | 112 (59–151) |
| D98% PTV (BED10), Gy | 64 (28–98) |
| D1% PTV (BED10), Gy | 110 (58–149) |
| Dave PTV (between D1% and D98%) (BED10), Gy | 86 (51–121) |
| Dave PTV (between D1% and prescribed dose) (BED10), Gy | 96 (50–126) |
| PTV coverage, % | 87 (40–100) |
| Paddick conformity index | 0,72 (0.1–0.89) |
| Dmax trachea (EQD2 3/α = 3), Gy | 8 (0–155) |
| Dmax bronchi (EQD2 3/α = 3), Gy | 65 (0–188) |
| Dmax eosophagus (EQD2 3/α = 3), Gy | 22 (2–91) |
| Dmax heart (EQD2 3/α = 3), Gy | 65 (0–173) |
| Dave homolateral lung (EQD2 3/α = 3), Gy | 6 (1–24) |
BED10: biologically effective dose with α/β = 10; D1%: dose received by 1% of PTV; D98%: dose received by 98% of PTV; D: dose; Dave: average dose; Dmax: maximum dose; Dmed: median dose; Dmin: minimum dose; EQD2: 2 Gy per fraction equivalent dose;GTV: gross tumour volume; PTV: planning target volume.